Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

Exclusion Criteria

• •Certain rare types of CTCL.
• •Previous treatment with other anti-CD4 medications.
• •More than two previous treatments with systemic chemotherapy.
• •Certain anti-psoriasis or anti-cancer therapies within the last 4 weeks before entering this trial.
• •Some types of steroid treatments less than two weeks before entering the trial.
• •Prolonged exposure to sunlight or UV light during the trial.
• •Other cancer diseases, except certain skin cancers or cervix cancer.
• •Chronic infectious disease requiring medication.
• •Certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, lung, heart, hormonal, nerve or blood diseases.
• •Pregnant or breast-feeding women.
• •Women of childbearing age who are unable or unwilling to use an IUD or hormonal birth control during the whole trial.
• •If you are participating in another trial with a different new drug 4 weeks before you enter this trial.